Pfizer agreed to lower prescription drug costs for Medicaid and invest $70 billion in US manufacturing, President Trump announced. This deal includes most-favoured-nation pricing for Medicaid, aiming to significantly reduce healthcare expenses. Pfizer's shares surged following the announcement, which precedes new US tariffs on branded drugs.from Business News Today: Stock Markets, Financial News, India Business & World Business News https://ift.tt/zNumyDf
https://ift.tt/CuDtTJv
